Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Filing Names

Seikagaku Corporation
Seikagaku Corporation Central Research Laboratorie

Seikagaku Corporation patents

Recent patent applications related to Seikagaku Corporation. Seikagaku Corporation is listed as an Agent/Assignee. Note: Seikagaku Corporation may have other listings under different names/spellings. We're not affiliated with Seikagaku Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Seikagaku Corporation-related inventors

Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease

Provided is a chondroitin sulfate derivative having a structure cross-linked with a group in a polyvalent amine. Also provided is a composition containing the chondroitin sulfate derivative. Also provided are an agent and method for the treatment of an eye disease, the agent and method having a therapeutic effect on... Seikagaku Corporation

Chondroitin sulfate derivative and agent for treating bladder diseases

—HN—(CH2)m—CHR1—CO—  (I)... Seikagaku Corporation

Agent for improving ocular subjective symptoms and method thereof

Provided is an agent for improving human ocular subjective symptoms containing hyaluronic acid having an aminoalkyl cinnamate covalently bonded thereto.... Seikagaku Corporation

Method for measuring endotoxin

(3) a proclotting enzyme of a horseshoe crab.... Seikagaku Corporation

Anti-chondroitin-sulfate-e antibody

The present invention provides an antibody that can react with chondroitin sulfate E at a high specificity and that can be used for, for example, the detection, isolation, and so forth, of specific sulfated polysaccharides. The present invention relates to a novel anti-chondroitin sulfate E antibody that reacts with chondroitin... Seikagaku Corporation

Pharmaceutical composition for relieving pain

The pharmaceutical composition of the present invention is an intra-articular formulation that exerts rapid analgesic effects after administration, and shows extremely long durable effects for a human joint disease with only a single administration rather than multiple administrations of a conventional way.... Seikagaku Corporation

Therapeutic agent for disc herniation

The present invention provides a therapeutic agent for disc herniation, which has extremely few adverse side effects, can achieve a prolonged pain-ameliorating effect when administered in only a single dose, and can exhibit a high therapeutic effect and high safety in clinical applications. The present invention relates to a therapeutic... Seikagaku Corporation

Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials

[the symbols in the formula are as described in the specification]; a crosslinked acidic polysaccharide obtained by forming crosslinks by amide bonding between the amino groups in the diamine crosslinking agent and carboxyl groups in an acidic polysaccharide; and a medical material including the crosslinked product.... Seikagaku Corporation

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Seikagaku Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Seikagaku Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by